Delivery Order SPE2DE24D0013-SPE2D625F2PSJ
- Not listed
- The U.S. Defense Department's Medical Supply Chain has awarded a $5,082 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2 testing supplies. The contract, awarded on August 4, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation and will be performed at Cepheid's primary facility in Sunnyvale. This delivery order falls under Cepheid's existing indefinite delivery vehicle...
- The U.S. Defense Department's Medical Supply Chain division awarded a $17,280 firm fixed-price delivery order to Cepheid Inc. on August 27, 2025, with an ultimate completion date of September 4, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, a Sunnyvale, California-based manufacturer of advanced diagnostic systems and test kits, was selected without a set-aside...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $81,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems. Issued on September 5, 2025, with an ultimate completion date of September 12, 2025, this delivery order (Contract No. 4569359238) carries no set-aside designation and represents a continuation of the government's procurement of Cepheid's diagnostic solutions. The work will be performed at...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, on September 10, 2025. The delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, carries no set-aside designation. This award represents a procurement of diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance completion targeted for September 16, 2025. The contract contains no set-aside designation and represents a...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's...
- The Defense Department's Medical Supply Chain agency awarded a $1,540 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 3, 2025, with an ultimate completion date of September 10, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and represents a delivery order likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans...
- The U.S. Defense Department's Medical Supply Chain division awarded a firm fixed-price delivery order valued at $1,297.80 to Cepheid Inc. on September 4, 2025, with an ultimate completion date of September 11, 2025. The award, contract number GXGBSLBXC-10, carries no set-aside designation and will be performed in Sunnyvale, California, where Cepheid maintains its headquarters. As a leading manufacturer of molecular diagnostic solutions, Cepheid specializes in advanced diagnostic systems and test...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2PSJDelivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $9,240 delivery order (Contract No. 4569343611) to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 4, 2025. The delivery order calls for the supply of COVID-19 and virus test kits, with an ultimate completion date of September 11, 2025. This firm fixed-price contract carries no set-aside designation and represents a specific procurement requirement fulfilled under Cepheid's existing federal contracting relationships. The order reflects the continued demand for rapid diagnostic testing capabilities within defense-affiliated healthcare supply chains. Cepheid specializes in advanced molecular diagnostic systems and testing solutions for infectious diseases, including COVID-19, influenza, RSV, and other communicable conditions. The company maintains an established presence in the federal market through multiple indefinite delivery contracts with the Department of Veterans Affairs, including significant agreements valued at $32.8 million and $2.5 million for diagnostic reagents and PCR testing services. This delivery order aligns with Cepheid's core business operations providing diagnostic test kits to federal healthcare systems and demonstrates the Medical Supply Chain's reliance on the company's proven diagnostic capabilities to support defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 9/4/25 |